Causality-Inspired Taxonomy for Explainable Artificial Intelligence

As two sides of the same coin, causality and explainable artificial intelligence (xAI) were initially proposed and developed with different goals. However, the latter can only be complete when seen through the lens of the causality framework. As such, we propose a novel causality-inspired framework for xAI that creates an environment for the development of xAI approaches. To show its applicability, biometrics was used as case study. For this, we have analysed 81 research papers on a myriad of biometric modalities and different tasks. We have categorised each of these methods according to our novel xAI Ladder and discussed the future directions of the field

A model of urban scaling laws based on distance dependent interactions

Socio-economic related properties of a city grow faster than a linear relationship with the population, in a log–log plot, the so-called superlinear scaling. Conversely, the larger a city, the more efficient it is in the use of its infrastructure, leading to a sublinear scaling on these variables. In this work, we addressed a simple explanation for those scaling laws in cities based on the interaction range between the citizens and on the fractal properties of the cities. To this purpose, we introduced a measure of social potential which captured the influence of social interaction on the economic performance and the benefits of amenities in the case of infrastructure offered by the city. We assumed that the population density depends on the fractal dimension and on the distance-dependent interactions between individuals. The model suggests that when the city interacts as a whole, and not just as a set of isolated parts, there is improvement of the socio-economic indicators. Moreover, the bigger the interaction range between citizens and amenities, the bigger the improvement of the socio-economic indicators and the lower the infrastructure costs of the city. We addressed how public policies could take advantage of these properties to improve cities development, minimizing negative effects. Furthermore, the model predicts that the sum of the scaling exponents of social-economic and infrastructure variables are 2, as observed in the literature. Simulations with an agent-based model are confronted with the theoretical approach and they are compatible with the empirical evidences

Projeto escola de tempo complementar (PETCOM) e ensino de Química: Uma realidade na escola SESI Dolores Peres Gomes da Silva (rede SESIMINAS de educação) em Ituiutaba

..

Evaluation of herbaceous cotton lines and cultivars in the northeast of Brazil. II. Agronomic and fiber characteristics

Avaliou-se o desempenho de novas linhagens de algodoeiro herbáceo, frente às cultivares em uso, originadas do próprio CNPA e de outras instituições de pesquisa do País. Observaram-se os aspectos de peso médio de um capulho, percentagem de fibra, comprimento, uniformidade, finura e resistência de fibra. Os dados foram fornecidos por dezenove ensaios regionais de cultivares de algodoeiro herbáceo delineados em blocos ao acaso, com nove tratamentos e oito repetições, e conduzidos em diferentes localidades dos Estados do Piauí, Ceará, Rio Grande do Norte, Paraíba, Pernambuco. Magoas e Bahia, nos anos agrícolas 1980/81 e 1981/82. IAC 17 e CNPA 78-SME4 detiveram as maiores médias para peso médio de capulho. A primeira atingiu a maior média para percentagem de fibra (40,1%), tendo as linhagens PR 4139 (39,1%) e CNPA 76-6555 (38,9%) se destacado, também, para este aspecto. O comprimento de fibra variou de 29,1 mm a 31,7 mm, destacando-se a CNPA 78-SME4, com a maior média. As linhagens apresentaram médias de uniformidade de fibra variando de 51,0% a 54,2%, finura de fibra variando de 4,2 a 4,9 e resistência de fibra de 7,3 a 8,1.Eight lines of upland cotton were evaluated together with cultivars developed by the Centro Nacional de Pesquisa de Algodão (CNPA) and by other research institutions in the country. The following characteristics were observed: boll weight, lint percent and fiber length, uniformity, fineness and resistance. The data were collected in 19 regional cotton variety tests, planted in a complete randomized block design with nine treatments and eight replications, at different locations in the States of Piauí, Ceará, Rio Grande do Norte, Paraíba, Pernambuco, Alagoas and Bahia, in the years of 1980/81 and 1981/82. The genotypes IAC 17 and CNPA 78-SME4 had the highest boll weight. For lint percent the genotypes had the highest mean values, were IAC 17 (40.1%), PR 4139 (39.1%) and CNPA 76-6555 (38.9%). Fiber length varied from 29.1 mm to 31.7 mm with CNPA 78-SME4 having the highest mean value. For the other fiber characteristics the results were: uniformity varying from 51.0 to 54.2%, fineness from 4.2 to 4.9 and resistance from 7.3 to 8.1

Irs2 Silencing Increases Apoptosis And Potentiates The Effects Of Ruxolitinib In Jak2v617f-positive Myeloproliferative Neoplasms.

The recurrent V617F mutation in JAK2 (JAK2V617F) has emerged as the primary contributor to the pathogenesis of myeloproliferative neoplasms (MPN). However, the lack of complete response in most patients treated with the JAK1/2 inhibitor, ruxolitinib, indicates the need for identifying pathways that cooperate with JAK2. Activated JAK2 was found to be associated with the insulin receptor substrate 2 (IRS2) in non-hematological cells. We identified JAK2/IRS2 binding in JAK2V617F HEL cells, but not in the JAK2WT U937 cell line. In HEL cells, IRS2 silencing decreased STAT5 phosphorylation, reduced cell viability and increased apoptosis; these effects were enhanced when IRS2 silencing was combined with ruxolitinib. In U937 cells, IRS2 silencing neither reduced cell viability nor induced apoptosis. IRS1/2 pharmacological inhibition in primary MPN samples reduced cell viability in JAK2V617F-positive but not JAK2WT specimens; combination with ruxolitinib had additive effects. IRS2 expression was significantly higher in CD34+ cells from essential thrombocythemia patients compared to healthy donors, and in JAK2V617F MPN patients when compared to JAK2WT. Our data indicate that IRS2 is a binding partner of JAK2V617F in MPN. IRS2 contributes to increased cell viability and reduced apoptosis in JAK2-mutated cells. Combined pharmacological inhibition of IRS2 and JAK2 may have a potential clinical application in MPN.

Evaluation of in vitro Antifungal Activity of Xylosma prockia (Turcz.) Turcz. (Salicaceae) Leaves Against Cryptococcus spp.

Cryptococcus species are responsible for important systemic mycosis and are estimated to cause millions of new cases annually. The available therapy is limited due to the high toxicity and the increasing rates of yeast resistance to antifungal drugs. Popularly known as “sucará,” Xylosma prockia (Turcz.) Turcz. (Salicaceae) is a native plant from Brazil with little information on its pharmacological potential. In this work, we evaluated in vitro anticryptococcal effects of the leaf ethanolic extract of X. prockia and its fractions against Cryptococcus gattii and Cryptococcus neoformans. We also evaluated phenotypic alterations caused by ethyl acetate fraction (EAF) (chosen according to its biological results). The liquid chromatography–mass spectrometry (LC-MS) analysis of EAF demonstrated the presence of phenolic metabolites that belong to three structurally related groups as majority compounds: caffeoylquinic acid, coumaroyl-glucoside, and caffeoyl-glucoside/deoxyhexosyl-caffeoyl glucoside derivatives. The minimum inhibitory concentration (MIC) values against C. gattii and C. neoformans ranged from 8 to 64 mg/L and from 0.5 to 8 mg/L, for ethanolic extract and EAF, respectively. The EAF triggered an oxidative burst and promoted lipid peroxidation. EAF also induced a reduction of ergosterol content in the pathogen cell membrane. These effects were not associated with alterations in the cell surface charge or in the thermodynamic fingerprint of the molecular interaction between EAF and the yeasts evaluated. Cytotoxic experiments with peripheral blood mononuclear cells (PBMCs) demonstrated that EAF was more selective for yeasts than was PBMCs. The results may provide evidence that X. prockia leaf extract might indeed be a potential source of antifungal agents.Fil: Folly, Mariany L. C.. Universidade Federal de Juiz de Fora; BrasilFil: Ferreira, Gabriella F.. Universidade Federal de Juiz de Fora; BrasilFil: Salvador, Maiara R.. Universidade Federal de Juiz de Fora; BrasilFil: Sathler, Ana A.. Universidade Federal de Juiz de Fora; BrasilFil: da Silva, Guilherme F.. Universidade Federal de Juiz de Fora; BrasilFil: Santos, Joice Castelo Branco. Ceuma University; BrasilFil: Santos, Julliana R. A. dos. Ceuma University; BrasilFil: Nunes Neto, Wallace Ribeiro. Ceuma University; BrasilFil: Rodrigues, João Francisco Silva. Ceuma University; BrasilFil: Fernandes, Elizabeth Soares. Ceuma University; BrasilFil: da Silva, Luís Cláudio Nascimento. Ceuma University; BrasilFil: de Freitas, Gustavo José Cota. Universidade Federal de Minas Gerais; BrasilFil: Denadai, Ângelo M.. Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas; BrasilFil: Rodrigues, Ivanildes V.. Universidade Federal de Juiz de Fora; BrasilFil: Mendonça, Leonardo M.. Universidade Federal de Juiz de Fora; BrasilFil: Monteiro, Andrea Souza. Ceuma University; BrasilFil: Santos, Daniel Assis. Universidade Federal de Minas Gerais; BrasilFil: Cabrera, Gabriela Myriam. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Unidad de Microanálisis y Métodos Físicos en Química Orgánica. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Unidad de Microanálisis y Métodos Físicos en Química Orgánica; ArgentinaFil: Siless, Gastón Ezequiel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Unidad de Microanálisis y Métodos Físicos en Química Orgánica. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Unidad de Microanálisis y Métodos Físicos en Química Orgánica; ArgentinaFil: Lang, Karen L.. Universidade Federal de Juiz de Fora; Brasi

Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial

<p>Abstract</p> <p>Background</p> <p>Blood pressure (BP) within pre-hypertensive levels confers higher cardiovascular risk and is an intermediate stage for full hypertension, which develops in an annual rate of 7 out of 100 individuals with 40 to 50 years of age. Non-drug interventions to prevent hypertension have had low effectiveness. In individuals with previous cardiovascular disease or diabetes, the use of BP-lowering agents reduces the incidence of major cardiovascular events. In the absence of higher baseline risk, the use of BP agents reduces the incidence of hypertension. The PREVER-prevention trial aims to investigate the efficacy, safety and feasibility of a population-based intervention to prevent the incidence of hypertension and the development of target-organ damage.</p> <p>Methods</p> <p>This is a randomized, double-blind, placebo-controlled clinical trial, with participants aged 30 to 70 years, with pre-hypertension. The trial arms will be chlorthalidone 12.5 mg plus amiloride 2.5 mg or identical placebo. The primary outcomes will be the incidence of hypertension, adverse events and development or worsening of microalbuminuria and of left ventricular hypertrophy in the EKG. The secondary outcomes will be fatal or non-fatal cardiovascular events: myocardial infarction, stroke, heart failure, evidence of new sub-clinical atherosclerosis, and sudden death. The study will last 18 months. The sample size was calculated on the basis of an incidence of hypertension of 14% in the control group, a size effect of 40%, power of 85% and P alpha of 5%, resulting in 625 participants per group. The project was approved by the Ethics committee of each participating institution.</p> <p>Discussion</p> <p>The early use of blood pressure-lowering drugs, particularly diuretics, which act on the main mechanism of blood pressure rising with age, may prevent cardiovascular events and the incidence of hypertension in individuals with hypertension. If this intervention shows to be effective and safe in a population-based perspective, it could be the basis for an innovative public health program to prevent hypertension in Brazil.</p> <p>Trial Registration</p> <p>Clinical Trials <a href="http://www.clinicaltrials.gov/ct2/show/NCT00970931">NCT00970931</a>.</p